Sale price$105.27
Est. Delivery:
%3Cp%3EEarn%20[points_amount]%20when%20you%20buy%20this%20item.%3C/p%3E

Shop with Confidence

+
+
+

Description

  • Nasal Device with 3mL Syringe 25

Product Specs

Item Number 1213911
Catalog Number DART100
UOM BX
Level 1 Family Description Respiratory Products
Level 2 Category Description Respiratory Therapy
Level 3 Group Description Aerosol Administration
Level 4 Sub-Category Description Nebulizer Accessories
Application Intranasal Mucosal Atomization Device
Brand DART
Buy American Act (BAA) Compliant No
Country of Origin Unknown
For Use With For Atomized medication delivery
Manufacturer Pulmodyne
Manufacturer # DART100
McKesson # 1213911
Specifications 3 mL
Trade Agreement Act (TAA) Compliant No
UNSPSC Code 42271925

Frequently asked questions

Does this device ensure efficient medication delivery?

Yes, the DART device is specifically engineered for targeted intranasal mucosal atomization. This design facilitates the rapid absorption of therapeutic agents directly through the nasal mucosa, providing a reliable and non-invasive delivery method for clinical environments.

Is this a complete, ready-to-use kit?

Absolutely. Each unit comes as a fully integrated system that includes: <ul><li>1 Nasal Atomization Device</li><li>1 3 mL Syringe</li></ul> This ensures you have everything needed for immediate application right out of the package.

Can I accurately measure medications with the syringe?

Yes, the syringe features a high-clarity barrel with bold, easy-to-read volume graduation markings. This allows for precise measurement, which is essential for accurate dosage in respiratory therapy workflows.

Is this device suitable for critical care settings?

Yes, the DART device is a professional-grade accessory designed with reliability in mind. It is ideal for clinical environments where efficient and precise aerosol administration is a priority.

Is the atomizing tip comfortable for the patient?

The device features a specialized conical-shaped tip that is designed for secure and comfortable placement within the nostril, ensuring the user can maintain proper positioning during medication delivery.

Does it offer a non-invasive alternative to other methods?

Yes, the intranasal mucosal route is an excellent non-invasive alternative for medication delivery. It bypasses the need for intravenous access or other more invasive procedures, making it highly effective for specific respiratory and aerosol treatments.

Are the materials safe for clinical use?

The DART device is constructed from high-clarity medical-grade materials. It is intended as a single-use accessory, ensuring that each administration is sterile, safe, and consistent with clinical standards.

How is the device categorized in medical workflows?

This device falls under the category of Respiratory Therapy, specifically for aerosol administration. It is a vital tool for clinicians focusing on efficient respiratory support.

What is the primary benefit of the atomized delivery?

The primary benefit of atomization via this device is rapid absorption. By converting medication into an aerosol mist specifically for the nasal mucosa, it allows for quicker therapeutic action compared to standard delivery methods.

Is this a specialized tool for professionals?

Yes, the DART 3 mL system is specifically designed for healthcare professionals. Its functional design, precise measurement capabilities, and targeted delivery system are tailored for clinical professionals who require accuracy in aerosol therapy.